Description

The task Force provides a platform for discussions on academic clinical trials. It facilitates an exchange of best practices and pinpoints the challenges that researchers face in this field. It also aims to better communicate the value of researchers’ work in society and the value of academic clinical trials. It is committed to providing recommendations to reduce inconsistencies in the regulatory framework and advocates for adequate funding.

Experts

This task force is chaired by Professor Colm O'Morain.

Highlights

  • Policy paper: Moving forward from drug-centered to patient-centered clinical research

    BioMed Alliance members contributed to a White Paper initiated by EORTC on academic clinical research.
  • European Respiratory Journal Article

    An updated version of the white paper entitled: ‘Moving forward from drug-centred to patient-centred research’ was published in the European Respiratory Journal in February 2019. This article includes the patient perspective and describes specific policy angles to tackle related issues. The article can be found here.

We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.